These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2744894)

  • 1. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival.
    Silver HK; Karim KA; Le Riche J; de Jong G; Spinelli J; Worth A; McLean DI; Gallagher R
    Int J Cancer; 1989 Jul; 44(1):31-4. PubMed ID: 2744894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid.
    Silver HK; Murray RN; Worth AJ; Salinas FA; Spinelli JJ
    Int J Cancer; 1983 Jan; 31(1):39-43. PubMed ID: 6832847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
    Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
    Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric DNA analysis in colorectal cancer].
    Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
    Scheistrøen M; Tropé C; Koern J; Pettersen EO; Abeler VM; Kristensen GB
    Cancer; 1995 Jan; 75(1):72-80. PubMed ID: 7804980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialic acid elevations in malignant melanoma patients.
    Silver HK; Rangel DM; Morton DL
    Cancer; 1978 Apr; 41(4):1497-9. PubMed ID: 639006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of flow cytometric DNA analysis in patients with rectal cancer].
    Yamasaki S; Kumashiro R; Yoshitake H; Sano C; Maekawa T; Kido K; Tanaka K; Inutsuka S
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):775-9. PubMed ID: 8489285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy and cell cycle analysis in ear malignant melanoma by flow and image cytometry.
    Cohen C; Walker BF; Solomon AR; DeRose PB
    Anal Quant Cytol Histol; 1992 Apr; 14(2):81-8. PubMed ID: 1590901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
    Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignancy of hepatocellular carcinoma evaluated with nuclear DNA ploidy pattern].
    Kamiyama T; Uchino J; Une Y; Ishizu H
    Nihon Rinsho; 1992 Oct; 50(10):2408-12. PubMed ID: 1333017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.